Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458507076976v1
13/7/850    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, K.
Right arrow Articles by Nishizawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, K.
Right arrow Articles by Nishizawa, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on August 1, 2007
Multiple Sclerosis, Vol. 13, No. 7, 850-855 (2007)
DOI: 10.1177/1352458507076976

Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions

K. Tanaka

Department of Neurology, Brain Research Institute, Niigata University, Niigata Japan, keiko{at}bri.niigata-u.ac.jp

T. Tani

Department of Neurology, Brain Research Institute, Niigata University, Niigata Japan

M. Tanaka

Department of Neurology, Utano National Hospital, Kyoto, Japan

T. Saida

Department of Neurology, Utano National Hospital, Kyoto, Japan

J. Idezuka

Department of Neurology, Ojiya Sakura Hospital, Ojiya, Japan

M. Yamazaki

Department of Cellular and Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan

M. Tsujita

Department of Cellular and Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan

T. Nakada

Center for Integrated Human Brain Science, Brain Research Institute, Niigata University, Niigata, Japan

K. Sakimura

Department of Cellular and Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan

M. Nishizawa

Department of Neurology, Brain Research Institute, Niigata University, Niigata Japan

Multiple sclerosis (MS) in Asian populations is often characterized by the selective involvement of the optic nerve (ON) and spinal cord (SP) (OSMS) in contrast to classic MS (CMS), where frequent lesions are observed in the cerebrum, cerebellum or brainstem. In Western countries, inflammatory demyelinating disease preferentially involving the ON and SP is called neuromyelitis optica (NMO). Recently, Lennon et al. discovered that NMO-IgG, shown to bind to aquaporin 4 (AQP4), could be a specific marker of NMO and also of Japanese OSMS whose clinical features were identical to NMO having long spinal cord lesions extending over three vertebral segments (LCL). To examine this antibody in larger populations of Japanese OSMS patients in order to know its epidemiological and clinical spectra, we established an immunohistochemical detection system for the anti-AQP4 antibody (AQP4-Ab) using the AQP4-transfected human embryonic kidney cell line (HEK-293) and confirmed AQP4-Ab positivity together with the immunohistochemical staining pattern of NMO-IgG in approximately 60% of Japanese OSMS patients with LCL. Patients with OSMS without LCL and those with CMS were negative for this antibody. Our results accorded with those of Lennon et al. suggest that Japanese OSMS with LCL may have an underlying pathogenesis in common with NMO. Multiple Sclerosis 2007; 13: 850—855. http://msj.sagepub.com

Key Words: aquaporin 4 water channel • long spinal cord lesion • neuromyelitis optica • NMO-IgG • opticospinal multiple sclerosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Therapeutic Advances in Neurological DisordersHome page
T. Okamoto, M. Ogawa, Youwei Lin, M. Murata, S. Miyake, and T. Yamamura
Review: Treatment of neuromyelitis optica: Current debate
Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 43 - 52.
[Abstract] [PDF]